T1 Energy Inc. Common Stock vs Tempus AI — how do they compare? T1 Energy Inc. Common Stock trades at $2.71 (market cap $868.55M), while Tempus AI trades at $66.48 (market cap $12.40B). The key difference: Tempus AI is far larger — about 14.3× T1 Energy Inc. Common Stock's market cap, and Tempus AI is trading nearer its 52-week high, T1 Energy Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold T1 Energy Inc. Common Stock for 0 Days and Tempus AI for 23 Days on average.
| TE | TEM | |
|---|---|---|
Market Cap | $868.55M | $12.40B |
Volume | 19,771,934 | 6,036,503 |
Sector | Industrials | Broad Market / Factor |
52-Week High | $12.04 | $92.45 |
52-Week Low | $2.72 | $41.55 |
Typical Hold Time | 0 Days | 23 Days |
Enterprise Value | $1.64B | $13.03B |
Signals from Pluang's Aura AI — not financial advice
T1 Energy (TE) trades at $3.16, down 1.56% today, reflecting ongoing investor caution despite a mixed earnings history. The company shows significant revenue growth from $755M in 2025 to $997M in 2026 but remains deeply unprofitable with a -38.49% net margin. Recent news highlights strategic moves toward vertical integration in solar manufacturing and energy storage, including the G2_Austin facility development and new supply agreements, which are central to its growth narrative.
The investment case hinges on execution of vertical integration and policy tailwinds, offering substantial upside to the $8 consensus target, but high execution risk, persistent losses, and regulatory scrutiny present clear dangers. Analyst sentiment is mixed with a Moderate Buy rating, yet the stock's viability depends heavily on future profitability improvements from 2027 onward.
Tempus AI (TEM) trades at $68.22, up 0.34% on the day, with a bullish technical signal despite negative profitability. The stock has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Recent FDA clearance for its ECG-MR AI product and multiple data licensing agreements highlight ongoing business development. Revenue growth is projected from $1.27 billion in 2025 to $1.4 billion in 2026, though net losses persist.
The outlook is supported by strong analyst consensus (64% buy ratings) and a $72.60 price target, suggesting modest upside. Key risks include sustained negative cash flow from operations, high valuation multiples, and insider selling. Investment appeal hinges on the company's ability to translate top-line growth into profitability amid competitive and execution challenges.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
T1 Energy Inc. manufactures photovoltaic solar modules and cells in US, operating a solar manufacturing facility in Texas acquired from Trina Solar. The company was formerly known as FREYR Battery before rebranding as T1 Energy in 2025 and changing its NYSE ticker from FREY to TE.
Read more on TE →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →